A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer
NCT07287748
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
38
Enrollment
INDUSTRY
Sponsor class
Conditions
DTC - Differentiated Thyroid Cancer
Interventions
DRUG:
[211At]NaAt
Sponsor
Alpha Fusion Inc.